Document is current
Any future updates will be listed below
-
Authors
Siebert, Stefanie
Kersten, Jane
Tomanek, Annika
Heinz, Sarina
Niels, Timo
Baumann, Freerk T.
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70113312, 70113312)
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 19 March 2025
Accepted: 23 June 2025
First Online: 22 July 2025
Declarations
:
: The study was approved by the Ethics Commission of the German Sport University Cologne (reference number 43/2015) as well as the Ethics Commission of Cologne University’s Faculty of Medicine (reference number 17–157) and has been registered in the German Clinical Trials Register on 10/15/2020 (DRKS-ID: DRKS00023287).
: During the course of the study, personal data, treatment data, and information about the disease from all participants, who provided written consent, were collected. This data, specifically diagnostic findings, is bound to professional discretion as well as data protection rules. A legal basis for working with the collected data comes from within the General Data Protection Regulations (GDPR), the Declaration of Helsinki, and the Good Clinical Practice Guidelines. Participation in this study is voluntary and refusing to participate did not have any disadvantages for the patient.
: The authors declare no competing interests.
